Filing Details
- Accession Number:
- 0001104659-11-004847
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-03 17:48:20
- Reporting Period:
- 2011-02-01
- Filing Date:
- 2011-02-03
- Accepted Time:
- 2011-02-03 17:48:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1289850 | Neurometrix Inc. | NURO | Surgical & Medical Instruments & Apparatus (3841) | 043308180 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1491139 | Krishnamurthy Balachandran | C/O Neurometrix, Inc. 62 Fourth Avenue Waltham MA 02451 | Sr. Vice President & Gm, Int. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-05-19 | 10,000 | $1.25 | 10,000 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2011-02-01 | 17,325 | $0.00 | 27,325 | No | 4 | A | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | A | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options (right to buy Common Stock) | Acquisiton | 2011-02-01 | 28,140 | $0.00 | 28,140 | $0.55 |
| Common Stock | Stock Options (right to buy Common Stock) | Acquisiton | 2011-02-01 | 42,210 | $0.00 | 42,210 | $0.55 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 28,140 | 2021-02-01 | No | 4 | A | Direct | |
| 42,210 | 2021-02-01 | No | 4 | A | Direct |
Footnotes
- Represents restricted stock that is subject to the Issuer's lapsing forfeiture right, which will lapse as follows: 50% on February 1, 2012 and 12.5% each quarter thereafter.
- This option vests as follows: 25% shall vest on February 1, 2012 and additionally 6.25% shall vest each quarter thereafter.
- These options vest on the achievement of certain revenue-related and cash flow targets.
Billionaire Hedge Funds
